ASX - By Stock
|
FMG |
Re:
Iron ore price
|
|
antmol89
|
52K |
28M |
6 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
52K
|
28M
|
6
|
|
ASX - By Stock
|
FEX |
Re:
Next update
|
|
antmol89
|
195 |
54K |
3 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
195
|
54K
|
3
|
|
ASX - By Stock
|
FEX |
Re:
Chart
|
|
antmol89
|
1.5K |
513K |
5 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
1.5K
|
513K
|
5
|
|
ASX - By Stock
|
FEX |
Re:
What should FEX do with all their cash
|
|
antmol89
|
180 |
69K |
0 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
180
|
69K
|
0
|
|
ASX - By Stock
|
FEX |
Re:
Ann: Quarterly Activities Report
|
|
antmol89
|
33 |
12K |
5 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
33
|
12K
|
5
|
|
ASX - By Stock
|
FEX |
Re:
next boat
|
|
antmol89
|
1.4K |
461K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
1.4K
|
461K
|
0
|
|
ASX - By Stock
|
FMG |
Re:
Ann: Successful Completion US$1,500m High Yeild Bond Offer
|
|
antmol89
|
31 |
13K |
15 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
31
|
13K
|
15
|
|
ASX - By Stock
|
FMG |
Re:
Iron ore price
|
|
antmol89
|
52K |
28M |
1 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
52K
|
28M
|
1
|
|
ASX - By Stock
|
FMG |
Re:
FMG Technical Analysis
|
|
antmol89
|
11K |
10M |
0 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
11K
|
10M
|
0
|
|
ASX - By Stock
|
FEX |
Re:
Ann: Maiden shipment of Iron Ridge product dispatched
|
|
antmol89
|
208 |
60K |
1 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
208
|
60K
|
1
|
|
ASX - By Stock
|
FMG |
Re:
Ann: Half Year Results to 31 December 2020
|
|
antmol89
|
6 |
3.6K |
2 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
6
|
3.6K
|
2
|
|
ASX - By Stock
|
FEX |
Re:
Media Releases
|
|
antmol89
|
843 |
294K |
3 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
843
|
294K
|
3
|
|
ASX - By Stock
|
FEX |
Re:
fex 2021
|
|
antmol89
|
788 |
238K |
1 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
788
|
238K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Trading halt
|
|
antmol89
|
483 |
161K |
7 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
483
|
161K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Train is leaving the station
|
|
antmol89
|
1.2K |
384K |
7 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
1.2K
|
384K
|
7
|
|
ASX - By Stock
|
APT |
Re:
APT should buy PayPal
|
|
antmol89
|
10 |
2.9K |
1 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
10
|
2.9K
|
1
|
|
ASX - By Stock
|
APT |
APT should buy PayPal
|
|
antmol89
|
10 |
2.9K |
2 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
10
|
2.9K
|
2
|
|
ASX - By Stock
|
QFE |
Re:
Ann: Investor presentation - FY20 results
|
|
antmol89
|
41 |
19K |
1 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
41
|
19K
|
1
|
|
ASX - By Stock
|
QFE |
Re:
Ann: Investor presentation - FY20 results
|
|
antmol89
|
41 |
19K |
2 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
41
|
19K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
antmol89
|
13 |
5.1K |
3 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
13
|
5.1K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
antmol89
|
134 |
55K |
0 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
134
|
55K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
antmol89
|
124 |
51K |
0 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
124
|
51K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
antmol89
|
124 |
51K |
3 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
124
|
51K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
antmol89
|
124 |
51K |
2 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
124
|
51K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
antmol89
|
124 |
51K |
1 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
124
|
51K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
$2.4 mil after-hours cross-trade immediately prior to the trading halt
|
|
antmol89
|
11 |
8.1K |
1 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
11
|
8.1K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Trading Halt
|
|
antmol89
|
17 |
9.6K |
1 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
17
|
9.6K
|
1
|
|
International Markets
|
SP500 |
Re:
BBUS
|
|
antmol89
|
14K |
3.8M |
2 |
05/06/20 |
05/06/20 |
International Markets
|
14K
|
3.8M
|
2
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
antmol89
|
43 |
22K |
1 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
43
|
22K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
antmol89
|
43 |
22K |
1 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
43
|
22K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
antmol89
|
43 |
22K |
0 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
43
|
22K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Opthea Chart
|
|
antmol89
|
309 |
170K |
5 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
309
|
170K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
antmol89
|
43 |
22K |
1 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
43
|
22K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
antmol89
|
43 |
22K |
3 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
43
|
22K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
|
|
antmol89
|
22 |
8.8K |
8 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
22
|
8.8K
|
8
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
|
|
antmol89
|
22 |
8.8K |
2 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
22
|
8.8K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
|
|
antmol89
|
22 |
8.8K |
1 |
04/05/20 |
04/05/20 |
ASX - By Stock
|
22
|
8.8K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
|
|
antmol89
|
22 |
8.8K |
0 |
04/05/20 |
04/05/20 |
ASX - By Stock
|
22
|
8.8K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
antmol89
|
46 |
24K |
0 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
antmol89
|
9 |
4.1K |
0 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
9
|
4.1K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
antmol89
|
42 |
12K |
1 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
42
|
12K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
antmol89
|
42 |
12K |
3 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
42
|
12K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
antmol89
|
42 |
12K |
2 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
antmol89
|
38 |
16K |
1 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
38
|
16K
|
1
|
|
ASX - By Stock
|
WTC |
Re:
Ann: Update - Dividend/Distribution - WTC
|
|
antmol89
|
10 |
5.1K |
1 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
10
|
5.1K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at SVB Leerink Healthcare Conference
|
|
antmol89
|
24 |
124K |
0 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
24
|
124K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Recruitment in Ph2a Trial of OPT-302 in DME
|
|
antmol89
|
72 |
101K |
2 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
72
|
101K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
antmol89
|
38 |
16K |
1 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
38
|
16K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
What's the vehicle anyhow?
|
|
antmol89
|
161 |
65K |
3 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
161
|
65K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
antmol89
|
13K |
4.8M |
2 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
13K
|
4.8M
|
2
|
|